US 9856475
Formulations for treating amyloidosis
granted A61KA61K31/685A61K31/713
Quick answer
US patent 9856475 (Formulations for treating amyloidosis) held by ARCTURUS THERAPEUTICS, INC. expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/685, A61K31/713, A61K9/127